Life ScienceCompany
Spark Therapeutics M&A Summary
Spark Therapeutics has acquired 1 company of its own.
Spark Therapeutics’ largest acquisition to date was in 2016, when it acquired Genable Technologies for $15M. The Company’s most targeted sectors include life science (100%).
Spark Therapeutics Ownership
Who owns Spark Therapeutics?
Spark Therapeutics is owned by Roche Holding AG. It was acquired on February 25, 2019.
Spark Therapeutics Business Overview
Where is Spark Therapeutics headquartered?
Spark Therapeutics is headquartered in Philadelphia, Pennsylvania.
What is Spark Therapeutics’ revenue?
Spark Therapeutics disclosed revenue of 65M USD for 2018 and 12M USD for 2017.
How many employees does Spark Therapeutics have?
Spark Therapeutics has 50 employees.
What sector is Spark Therapeutics in?
Spark Therapeutics is a life science company.
When was Spark Therapeutics founded?
Spark Therapeutics was founded in 2013.
M&A Summary
-
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1